Novel Immunotherapy Shows Promise Against HIV in Phase 1 Clinical Trial

A novel immunotherapy drug – previously studied in blood cancers – has shown promise as a HIV therapeutic in a phase one clinical trial.

Related Keywords

Tim Schacker ,Altor Biosciences ,University Of Minnesota ,